Citigroup Global Markets Funding Luxembourg S.C.A.
27 January 2025
NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR TO ANY PERSON OR ADDRESS IN THE U.S.
Citigroup Global Markets Funding Luxembourg S.C.A.
Unlisted Structured Products Programme (the "Programme")
Admission of Structured Products issued under the Programme to trading on the London Stock Exchange's International Securities Market
Citigroup Global Markets Funding Luxembourg S.C.A. (the "Issuer") is pleased to announce that the London Stock Exchange plc has today approved admission particulars (the "Admissions Particulars") dated 27 January 2025 in relation to the admission to trading on the London Stock Exchange plc's International Securities Market of Structured Products issued under the Programme. The Admission Particulars contain details of the Programme and the Issuer.
To view the Admissions Particulars, please paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/8373U_1-2025-1-27.pdf
To view the documents incorporated by reference into the Admissions Particulars, please paste the following URL into the address bar of your browser and search by the Issuer:
https://apps.sfc.hk/productlistWeb/searchProduct/SIP.do
For further information please contact:
Citi APAC Eli Issuance Team
Email: dl.mag.ap.eli.fdd@citi.com
DISCLAIMER ‑ INTENDED ADDRESSEES
Please note that the information contained in the Admission Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified or referred to in the Admission Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Admission Particulars is not addressed. Prior to relying on the information contained in the Admission Particulars you must ascertain from the Admission Particulars whether or not you are part of the intended addressees of the information contained therein.
Your right to access the Admission Particulars is conditional upon complying with the above requirement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
